The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of neoadjuvant aromatase inhibitor therapy and the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and a low/intermediate risk Oncotype Dx Recurrence Score (≤ 25).
 
Maysa M. Abu-Khalaf
Research Funding - Clovis Oncology (Inst); Genentech (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst)
 
Sarah Schellhorn Mougalian
Stock and Other Ownership Interests - Coronado Biosciences; Gilead Sciences; Roche
Research Funding - Genentech
 
Tara Beth Sanft
Consulting or Advisory Role - bioTheranostics
Research Funding - bioTheranostics (Inst)
 
Erin Wysong Hofstatter
No Relationships to Disclose
 
Gina G. Chung
No Relationships to Disclose
 
Kerin B. Adelson
Consulting or Advisory Role - Wellpoint
Speakers' Bureau - Genomic Health
 
Andrea Silber
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis
 
Debra S. Brandt
Employment - Pfizer (I)
Other Relationship - NCCN
 
Kathleen E. Bober-Sorcinelli
No Relationships to Disclose
 
Neal Fishbach
Speakers' Bureau - Genomic Health
 
Wajih Zaheer Kidwai
No Relationships to Disclose
 
Kert D. Sabbath
No Relationships to Disclose
 
Michael DiGiovanna
Consulting or Advisory Role - Merck
Research Funding - Genentech (Inst)
Patents, Royalties, Other Intellectual Property - DAKO; NeoMarkers
Expert Testimony - Immunogen
 
William M. Sikov
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Abbvie; Celgene
 
Lajos Pusztai
Honoraria - BioTheranostics; Pfizer
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Foundation Medicine; Genentech; Merck